share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs John C

Novavax | 4: Statement of changes in beneficial ownership of securities

诺瓦瓦克斯医药 | 4：持股变动声明
SEC announcement ·  03/27 06:15
牛牛AI助手已提取核心信息
John C Jacobs, President and CEO of Novavax Inc. (NVAX), was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Jacobs after the action.
John C Jacobs, President and CEO of Novavax Inc. (NVAX), was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Jacobs after the action.
据报道，诺瓦瓦克斯公司（NVAX）总裁兼首席执行官约翰·雅各布斯于2024年3月1日参与了一项涉及该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。该报告没有提供有关雅各布斯在行动后持有的股票数量的信息。
据报道，诺瓦瓦克斯公司（NVAX）总裁兼首席执行官约翰·雅各布斯于2024年3月1日参与了一项涉及该公司股票的交易。公告中未披露该交易的具体细节，包括股票数量、股票性质、交易价格和股票总价值。该报告没有提供有关雅各布斯在行动后持有的股票数量的信息。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成，只对中国内地以外的地区提供。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。